B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

From skincare to supplements, these gift options are designed to pamper the mom who has it all and bring a little extra luxury to her life.

Find out what support is available from a GP when a person has dementia, including the role of the GP in dementia care. The GP can support a person even if they don't accept their diagnosis. General ...

A recovering ketamine addict from Portsmouth warns of the drug's dangers as use soars among young people. The number treated across the region was an increase on the previous year. The early ...

For over-the-counter ibuprofen, you should not take more than 1,200 milligrams per day. Consistently exceeding this amount ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

SZA Last week Weeks at no. 1 Weeks on chart Top Dawg/RCA/Sony Music Week of February 1, 2025 click to see more Top Dawg/RCA/Sony Music Rimas/Sony Music ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.